Eris Lifesciences acquires 9 Dermatology brands from Dr Reddy's Labs for Rs 275 crore Ruchika Sharma17 March 2023 11:38 AM ISTThe brands are largely in cosmetology segments like anti-acne, moisturisers, cleansers, anti-ageing, hair health, melasma etc.
Dr Reddy's Labs recalls 4320 bottles of Tacrolimus Capsules in US over packaging error Ruchika Sharma9 March 2023 12:15 PM ISTDr Reddy's initiated the Class II nationwide recall on February 8 this year.
Dr Reddys Labs net profit up 77 percent at Rs 1247 crore in Q3 Ruchika Sharma28 Jan 2023 11:00 AM ISTHyderabad: Dr Reddy's Laboratories has reported a 77 percent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended...
Dr Reddy's labs completes clinical studies of Rituximab biosimilar for filing in US, Europe Ruchika Sharma20 Jan 2023 3:30 PM ISTWith the successful completion of these clinical studies, Dr. Reddy’s is now preparing to file Biologics License Application (BLA) / Marketing...
Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer Ruchika Sharma16 Jan 2023 11:00 AM ISTThe in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...
Dr Reddy's Labs, Theranica collaborate for commercialisation of wearable migraine treatment Nerivio in India Ruchika Sharma12 Jan 2023 12:36 PM ISTNerivio is the FDA-cleared, prescribed, digitally connected, drug-free wearable device for the acute treatment of episodic and chronic migraine in...
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Tocilizumab biosimilar met primary, secondary endpoints in Phase 1 study: Dr Reddy's Labs Ruchika Sharma19 Dec 2022 5:14 PM ISTThe company is initiating a global Phase 3 study with the aim of comparing the efficacy, safety, tolerability and immunogenicity of DRL_TC with the...
Dr Reddy's Labs arm to sell certain assets, liabilities of Netherlands site Ruchika Sharma19 Dec 2022 11:32 AM IST"The agreed consideration for the assets and liabilities of the said site is EUR 1. Further DRRDBV has agreed to pay to the purchaser a compensation...
Dr Reddy's Labs arm Aurigene reports results of AUR101 in Phase II study in patients with moderate to severe psoriasis Ruchika Sharma16 Dec 2022 12:25 PM ISTAUR-101 is a potent, oral RORÏ’t inverse agonist, with high selectivity across other ROR isoforms and nuclear hormone receptors and expected to confer...
Sun Pharma, Dr Reddy's Labs recall products in US over manufacturing issues Ruchika Sharma5 Dec 2022 1:30 PM ISTThe health regulator further said the US-based arm of Sun Pharma is recalling 14,064 cartons of a medication to treat erosive esophagitis or heartburn...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
